These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17430157)

  • 1. Drug resistance in hepatoblastoma.
    Warmann SW; Fuchs J
    Curr Pharm Biotechnol; 2007 Apr; 8(2):93-7. PubMed ID: 17430157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
    Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model.
    Warmann S; Hunger M; Teichmann B; Flemming P; Gratz KF; Fuchs J
    Cancer; 2002 Oct; 95(8):1795-801. PubMed ID: 12365029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma.
    Warmann SW; Heitmann H; Teichmann B; Gratz KF; Ruck P; Hunger M; Fuchs J
    Pediatr Hematol Oncol; 2005; 22(5):373-86. PubMed ID: 16020127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma.
    Lieber J; Armeanu-Ebinger S; Fuchs J
    Int J Mol Sci; 2015 Feb; 16(2):4190-208. PubMed ID: 25690034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.
    von Schweinitz D; Hecker H; Harms D; Bode U; Weinel P; Bürger D; Erttmann R; Mildenberger H
    J Pediatr Surg; 1995 Jun; 30(6):845-52. PubMed ID: 7545228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future management strategies for relapsed or progressive hepatoblastoma.
    Venkatramani R; Furman WL; Fuchs J; Warmann SW; Malogolowkin MH
    Paediatr Drugs; 2012 Aug; 14(4):221-32. PubMed ID: 22702740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
    Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
    J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on diagnosis and treatment of hepatoblastoma.
    Cao Y; Wu S; Tang H
    Biosci Trends; 2024 Jan; 17(6):445-457. PubMed ID: 38143081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children's Hospital.
    Kueht M; Thompson P; Rana A; Cotton R; O'Mahony C; Goss J
    Pediatr Transplant; 2016 Jun; 20(4):515-22. PubMed ID: 27018238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
    Fuchs J; Wenderoth M; von Schweinitz D; Haindl J; Leuschner I
    Cancer; 1998 Dec; 83(11):2400-7. PubMed ID: 9840541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
    Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased efficacy of CDDP in a xenograft model of hepatoblastoma using the apoptosis sensitizer ABT-737.
    Lieber J; Dewerth A; Wenz J; Kirchner B; Eicher C; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Oncol Rep; 2013 Feb; 29(2):646-52. PubMed ID: 23229825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and therapeutic factors influencing the clinical outcome of hepatoblastoma after liver transplantation: A single-institute experience.
    Umeda K; Okajima H; Kawaguchi K; Nodomi S; Saida S; Kato I; Hiramatsu H; Ogawa E; Yoshizawa A; Okamoto S; Uemoto S; Watanabe K; Adachi S
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29341393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
    Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
    Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
    Fuchs J; Rydzynski J; Hecker H; Mildenberger H; Bürger D; Harms D; V Schweinitz D;
    Eur J Pediatr Surg; 2002 Aug; 12(4):255-61. PubMed ID: 12369004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
    Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
    Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.